Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 2307-2309, May 1, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mead, L. J.
Right arrow Articles by Campbell, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mead, L. J.
Right arrow Articles by Campbell, L. J.

Homozygous and Hemizygous Deletions of 9p Centromeric to the Interferon Genes in Lung Cancer1

Leeanne J. Mead, Matthew T. Gillespie2, Louis B. Irving and Lynda J. Campbell3

Victorian Cancer Cytogenetics Service, St. Vincent's Hospital, 41 Victoria Parade [L. J. M., L. J. C.], and St. Vincent's Institute of Medical Research, St. Vincent's Hospital, [M. T. G.], Fitzroy 3065, and Department of Respiratory Medicine, Heidelberg Repatriation Hospital, Heidelberg 3081 [L. B. I.], Australia

Cytogenetic analysis has indicated that deletion of chromosome 9p occurs in a significant number of non-small cell lung and mesothelioma tumors. Using paired oligonucleotide primers, we have undertaken an extensive analysis of 9p markers to determine homozygous and heterozygous loss of marker sequences. Homozygous loss of D9S169 and D9S171, both of which map centromeric to the IFN gene cluster, were noted in three cell lines (27%) and hemizygous deletions of one or both of these loci was found in a further six cell lines (54%). These data suggest the presence of a potential tumor suppressor gene for lung cancer in proximity to D9S169 and D9S171 at 9p21.

1 Supported by the Anti-Cancer Council of Victoria.

2 Recipient of an R. D. Wright Research Fellowship of the National Health and Medical Research Council of Australia.

3 To whom requests for reprints should be addressed.

Received 1/25/94. Accepted 3/18/94.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
Y. Tomizawa, J.-i. Adachi, T. Kohno, K. Hamada, R. Saito, M. Noguchi, Y. Matsuno, S. Hirohashi, N. Yamaguchi, and J. Yokota
Prognostic Significance of Allelic Imbalances on Chromosome 9p in Stage I Non-Small Cell Lung Carcinoma
Clin. Cancer Res., May 1, 1999; 5(5): 1139 - 1146.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.